Guo, Y.; Zhao, H.; Xu, H.; Gu, H.; Cao, Y.; Li, K.; Li, T.; Hu, T.; Wang, S.; Zhao, W.;
et al. Albumin-to-Alkaline Phosphatase Ratio as a Prognostic Biomarker for Spinal Fusion in Lumbar Degenerative Diseases Patients Undergoing Lumbar Spinal Fusion. J. Clin. Med. 2022, 11, 4719.
https://doi.org/10.3390/jcm11164719
AMA Style
Guo Y, Zhao H, Xu H, Gu H, Cao Y, Li K, Li T, Hu T, Wang S, Zhao W,
et al. Albumin-to-Alkaline Phosphatase Ratio as a Prognostic Biomarker for Spinal Fusion in Lumbar Degenerative Diseases Patients Undergoing Lumbar Spinal Fusion. Journal of Clinical Medicine. 2022; 11(16):4719.
https://doi.org/10.3390/jcm11164719
Chicago/Turabian Style
Guo, Youfeng, Haihong Zhao, Haowei Xu, Huida Gu, Yang Cao, Kai Li, Ting Li, Tao Hu, Shanjin Wang, Weidong Zhao,
and et al. 2022. "Albumin-to-Alkaline Phosphatase Ratio as a Prognostic Biomarker for Spinal Fusion in Lumbar Degenerative Diseases Patients Undergoing Lumbar Spinal Fusion" Journal of Clinical Medicine 11, no. 16: 4719.
https://doi.org/10.3390/jcm11164719
APA Style
Guo, Y., Zhao, H., Xu, H., Gu, H., Cao, Y., Li, K., Li, T., Hu, T., Wang, S., Zhao, W., & Wu, D.
(2022). Albumin-to-Alkaline Phosphatase Ratio as a Prognostic Biomarker for Spinal Fusion in Lumbar Degenerative Diseases Patients Undergoing Lumbar Spinal Fusion. Journal of Clinical Medicine, 11(16), 4719.
https://doi.org/10.3390/jcm11164719